In the news | 2nd March 2015

Early adoption of IDBS’ Bioprocess Platform puts Lonza Biologics ahead

Lab Manager

March 2015

Lab Manager explores how IDBS has helped Lonza Biologics to integrate and optimize its bioprocess activities, managing the complete laboratory-to-report lifecycle within one single system: Bioprocess Execution System.

Read the article here »

About IDBSContact us

More news

Shutterstock 1899051346 Scaled 768x512

Beating the Capacity Crunch: Rethinking the Biopharma Supply Chain to Avoid Shortages

One of the lasting legacies of the COVID-19 pandemic is heightened awareness of manufacturing challenges and supply chain vulnerabilities in the biopharma industry and the impact this can have on public health. Issues have occurred at every stage of the supply chain, from the availability of raw materials to quality concerns with active pharmaceutical ingredients (APIs), and finished dosage forms and restrictive cold chain requirements.

Read more